Search Results - "Kruczynski, A."

Refine Results
  1. 1

    F14512, a polyamine-vectorized anti-cancer drug, currently in clinical trials exhibits a marked preclinical anti-leukemic activity by Kruczynski, A, Pillon, A, Créancier, L, Vandenberghe, I, Gomes, B, Brel, V, Fournier, E, Annereau, J-P, Currie, E, Guminski, Y, Bonnet, D, Bailly, C, Guilbaud, N

    Published in Leukemia (01-11-2013)
    “…Chemotherapy remains mainly used for the treatment of acute myeloid leukemia (AML). However, in the past 3 decades limited progress has been achieved in…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Novel tetra-acridine derivatives as dual inhibitors of topoisomerase II and the human proteasome by Vispé, S., Vandenberghe, I., Robin, M., Annereau, J.P., Créancier, L., Pique, V., Galy, J.P., Kruczynski, A., Barret, J.M., Bailly, C.

    Published in Biochemical pharmacology (15-06-2007)
    “…Acridine derivatives, such as amsacrine, represent a well known class of multi-targeted anti-cancer agents that generally interfere with DNA synthesis and…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    Superior in vivo experimental antitumour activity of vinflunine, relative to vinorelbine, in a panel of human tumour xenografts by Hill, B.T, Fiebig, H.-H, Waud, W.R, Poupon, M.-F, Colpaert, F, Kruczynski, A

    Published in European journal of cancer (1990) (01-03-1999)
    “…The antitumour activity of vinflunine, 20′,20′-dichloro-3′,4′-dihydrovinorelbine, a fluorinated Vinca alkaloid obtained by reaction in superacid media, was…”
    Get full text
    Journal Article
  8. 8

    Characterization of cell death induced by vinflunine, the most recent Vinca alkaloid in clinical development by KRUCZYNSKI, A, ETIEVANT, C, PERRIN, D, CHANSARD, N, DUFLOS, A, HILL, B. T

    Published in British journal of cancer (07-01-2002)
    “…Vinflunine, the most recent Vinca alkaloid in clinical development, demonstrated superior antitumour activity to other Vincas in preclinical tumour models…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Preclinical antitumour activity of F 11782, a novel dual catalytic inhibitor of topoisomerases by KRUCZYNSKI, A, ETIEVANT, C, PERRIN, D, IMBERT, T, COLPAERT, F, HILL, B. T

    Published in British Journal of Cancer (01-12-2000)
    “…F 11782 is a novel inhibitor of topoisomerases I and II, with an original mechanism of action (Perrin et al, 2000). This study, aimed to define its anticancer…”
    Get full text
    Journal Article
  11. 11

    In vivo antitumor activity of F 11782, a non-intercalating dual catalytic inhibitor of topoisomerases I and II, against a panel of human tumor xenografts by Kruczynski, A, Ricome, C, Waud, W R, Hill, B T

    “…The marked in vivo antitumor activity of F 11782 against murine experimental tumors (Kruczynski et al., Br J Cancer 83: 1516-24, 2000) has now been confirmed…”
    Get more information
    Journal Article
  12. 12

    Detection of DNA-strand breaks in cells treated with F 11782, a catalytic inhibitor of topoisomerases I and II by Barret, J M, Montaudon, D, Etiévant, C, Perrin, D, Kruczynski, A, Robert, J, Hill, B T

    Published in Anticancer research (01-11-2000)
    “…F 11782, or 2", 3"-bis pentafluorophenoxyacetyl-4',6'-ethylidene-beta-D glucoside of 4'-phosphate-4'-dimethylepipodophyllotoxin 2N-methyl glucamine salt, is a…”
    Get more information
    Journal Article
  13. 13

    Characterisation of the influence of anti-gastrin, anti-epidermal growth factor, anti-oestradiol, and anti-luteinising hormone releasing hormone antibodies on the proliferation of 27 cell lines from the gastrointestinal tract by Darro, F, Camby, I, Kruczynski, A, Pasteels, J L, Martinez, J, Kiss, R

    Published in Gut (01-02-1995)
    “…Numerous data from published reports prove that the proliferation of gastrointestinal tumour cell lines are under the control of many hormones or growth…”
    Get full text
    Journal Article
  14. 14

    Evidence of a direct relationship between the increase in the in vitro passage number of human non-small-cell-lung cancer primocultures and their chemosensitivity by Kruczynski, A, Kiss, R

    Published in Anticancer research (01-03-1993)
    “…A pharmacologically relevant modelling was attempted for screening of new molecules potentially active against non-small-cell lung cancers (NSCLCs). It was in…”
    Get more information
    Journal Article
  15. 15

    DNA histogram typing in a series of 707 tumors of the central and peripheral nervous system by Salmon, I, Kruczynski, A, Camby, I, Levivier, M, Pasteels, J L, Brotchi, J, Kiss, R

    Published in The American journal of surgical pathology (01-10-1993)
    “…The diagnostic value of ploidy level was investigated in a series of 707 tumors (from 707 patients) of the central and peripheral nervous system. The series…”
    Get more information
    Journal Article
  16. 16

    The combination of the tetrazolium derivative reduction (MTT) and digital cell image analysis to monitor in vitro the cytotoxicity of anti-neoplastic drugs by Etievant, C, Kruczynski, A, Pauwels, O, Kiss, R

    Published in Anticancer research (01-01-1991)
    “…We assessed the in vitro drug-induced cytotoxicity by means of the rapid low-cost but weakly sensitive Thiazolyl blue (MTT) test, and the less rapid, higher…”
    Get more information
    Journal Article
  17. 17

    Vinflunine, the latest Vinca alkaloid in clinical development : A review of its preclinical anticancer properties by Kruczynski, Anna, Hill, Bridget T.

    Published in Critical reviews in oncology/hematology (01-11-2001)
    “…Vinflunine is a new Vinca alkaloid uniquely fluorinated, by the use of superacid chemistry, in a little exploited region of the catharanthine moiety. In vitro…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Spontaneous evolution of cytoplasmic lectin binding and nuclear size and deoxyribonucleic acid content in human colorectal cancers grafted onto nude mice by Jannot, M C, Kruczynski, A, Limouzy, A, Dangou, J M, Selves, J, Delsol, G, Martinez, J, Kiss, R

    Published in Laboratory investigation (01-04-1993)
    “…The development of certain biologic characteristics in human colorectal tumor xenografted onto nude mice are described with respect to their precocious…”
    Get more information
    Journal Article
  20. 20

    Bcl-2 down-regulation and tubulin subtype composition are involved in resistance of ovarian cancer cells to vinflunine by Estève, Marie-Anne, Carré, Manon, Bourgarel-Rey, Véronique, Kruczynski, Anna, Raspaglio, Giuseppina, Ferlini, Cristiano, Braguer, Diane

    Published in Molecular cancer therapeutics (01-11-2006)
    “…Vinflunine, a new microtubule-targeting drug, has a marked antitumor activity in vitro and in vivo . Here, we studied the mechanisms mediating resistance to…”
    Get full text
    Journal Article